Simultaneous Determination of Pharmaceuticals Using Two UV-Based Methods with Different Diluents: Comparative Analysis via ANOVA and Greenness Assessment
DOI:
https://doi.org/10.56782/pps.474Keywords:
UV spectrophotometric approach, Antiviral medications, One way ANOVA, Environmental sustainabilityAbstract
In this work, a UV spectrophotometric approach that is accurate, precise, and environmentally friendly Is proposed for concurrent quantification of Ritonavir and Nirmatrelvir in combination pharmaceutical form. While treating COVID-19, these antiviral medications are essential. The Q-absorbance method was created and validated in accordance with ICH criteria, and the simultaneous estimation method is constructed utilizing two distinct solvents. After being evaluated for linearity, accuracy, precision, robustness, and sensitivity, the suggested techniques showed great reproducibility and high correlation coefficients (r2 = 0.999). One-way ANOVA statistical comparison verified that the devised methodologies were reliable and consistent for pharmaceutical analysis, with no significant differences found.Furthermore, the Green Analytical Procedure Index (GAPI), AGREE, and BAGI criteria were used to assess the Ecological sustainability of these methods. The results demonstrated that the suggested approaches provide a greener substitute for traditional analytical procedures by drastically lowering solvent usage and the production of hazardous waste. The proposed UV spectrophotometric approaches offer a straightforward, economical, and dependable solution for the routine quality evaluation of Ritonavir and Nirmatrelvir in dosage forms.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Prapti Gawand, Reshma Jadhav, Ashish Jain, Priya Jagtap, Bhavesh Mahajan, Prathamesh Chaudhari, Vijay Jadhav, Namrata Mahajan
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
